These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 8139479)
1. The effect of dietary fat content on plasma noncholesterol sterol concentrations in patients with familial hypercholesterolemia treated with simvastatin. Chisholm A; Sutherland W; Ball M Metabolism; 1994 Mar; 43(3):310-4. PubMed ID: 8139479 [TBL] [Abstract][Full Text] [Related]
2. Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia. Thiery J; Creutzfeldt C; Creutzfeldt W; Walli AK; Seidel D Klin Wochenschr; 1990 Aug; 68(16):814-22. PubMed ID: 2214604 [TBL] [Abstract][Full Text] [Related]
3. The effect of Simvastatin on the plasma antioxidant concentrations in patients with hypercholesterolaemia. Human JA; Ubbink JB; Jerling JJ; Delport R; Vermaak WJ; Vorster HH; Lagendijk J; Potgieter HC Clin Chim Acta; 1997 Jul; 263(1):67-77. PubMed ID: 9247729 [TBL] [Abstract][Full Text] [Related]
4. Beneficial effect of simvastatin in patients with drug resistant familial hypercholesterolaemia. Lewis-Barned NJ; Ball MJ N Z Med J; 1992 Jul; 105(938):284-6. PubMed ID: 1495661 [TBL] [Abstract][Full Text] [Related]
5. Effect of simvastatin on high density lipoprotein subfractions and apolipoproteins in type IIa hypercholesterolemia. Crook D; Bruce R; Worthington M; Mulcahy D; Patterson D; Wynn V Cardiovasc Drugs Ther; 1992 Dec; 6(6):633-9. PubMed ID: 1292582 [TBL] [Abstract][Full Text] [Related]
6. Stanol ester margarine alone and with simvastatin lowers serum cholesterol in families with familial hypercholesterolemia caused by the FH-North Karelia mutation. Vuorio AF; Gylling H; Turtola H; Kontula K; Ketonen P; Miettinen TA Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):500-6. PubMed ID: 10669649 [TBL] [Abstract][Full Text] [Related]
7. Comparative effects of simvastatin and pravastatin on cholesterol synthesis in patients with primary hypercholesterolemia. Feillet C; Farnier M; Monnier LH; Percheron C; Colette C; Descomps B; Crastes De Paulet A Atherosclerosis; 1995 Dec; 118(2):251-8. PubMed ID: 8770319 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia. Bruckert E; De Gennes JL; Malbecq W; Baigts F Clin Cardiol; 1995 Nov; 18(11):621-9. PubMed ID: 8590530 [TBL] [Abstract][Full Text] [Related]
9. Dietary management of patients with familial hypercholesterolaemia treated with simvastatin. Chisholm A; Mann J; Sutherland W; Williams S; Ball M Q J Med; 1992; 85(307-308):825-31. PubMed ID: 1484945 [TBL] [Abstract][Full Text] [Related]
10. Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia. Naoumova RP; Marais AD; Mountney J; Firth JC; Rendell NB; Taylor GW; Thompson GR Atherosclerosis; 1996 Jan; 119(2):203-13. PubMed ID: 8808497 [TBL] [Abstract][Full Text] [Related]
12. Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia. Torvik K; Narverud I; Ottestad I; Svilaas A; Gran JM; Retterstøl K; Ellingvåg A; Strøm E; Ose L; Veierød MB; Holven KB Atherosclerosis; 2016 Sep; 252():21-27. PubMed ID: 27494447 [TBL] [Abstract][Full Text] [Related]
13. Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatin. Berger GM; Marais AD; Seftel HC; Baker SG; Mendelsohn D; Welsh NH; Joffe BI Cardiovasc Drugs Ther; 1989 Apr; 3(2):219-27. PubMed ID: 2487533 [TBL] [Abstract][Full Text] [Related]
14. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia. Pappu AS; Bacon SP; Illingworth DR J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia. Hoeg JM; Maher MB; Zech LA; Bailey KR; Gregg RE; Lackner KJ; Fojo SS; Anchors MA; Bojanovski M; Sprecher DL Am J Cardiol; 1986 Apr; 57(11):933-9. PubMed ID: 3515897 [TBL] [Abstract][Full Text] [Related]
16. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. Lambert M; Lupien PJ; Gagné C; Lévy E; Blaichman S; Langlois S; Hayden M; Rose V; Clarke JT; Wolfe BM; Clarson C; Parsons H; Stephure DK; Potvin D; Lambert J Pediatrics; 1996 May; 97(5):619-28. PubMed ID: 8628597 [TBL] [Abstract][Full Text] [Related]
17. Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system. Sandset PM; Lund H; Norseth J; Abildgaard U; Ose L Arterioscler Thromb; 1991; 11(1):138-45. PubMed ID: 1987991 [TBL] [Abstract][Full Text] [Related]
18. Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia. Steinmetz A; Schwartz T; Hehnke U; Kaffarnik H J Cardiovasc Pharmacol; 1996 Apr; 27(4):563-70. PubMed ID: 8847874 [TBL] [Abstract][Full Text] [Related]
19. [Effects of simvastatin on atherogenic blood lipid pattern]. Alessandri C; Peverini F; Basili S; Barsi R; Paradiso M; Marotta P; Censi C; Cordova C; Balsano F Recenti Prog Med; 1991 Apr; 82(4):225-9. PubMed ID: 1857842 [TBL] [Abstract][Full Text] [Related]